000			02156 a2200661 4500
005			20250517145833.0
264		0	_c20180129
008			201801s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdx163 _2doi
040			_aNLM _beng _cNLM
100	1		_aJain, P
245	0	0	_aCharacteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJul 2017
300			_a1554-1559 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aChromosome Aberrations
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKaryotype
650	0	4	_aLeukemia, Prolymphocytic, T-Cell _xgenetics
650	0	4	_aMedical Records
650	0	4	_aMultivariate Analysis
650	0	4	_aProportional Hazards Models
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aStem Cell Transplantation _xadverse effects
650	0	4	_aTexas
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aAoki, E
700	1		_aKeating, M
700	1		_aWierda, W G
700	1		_aO'Brien, S
700	1		_aGonzalez, G N
700	1		_aFerrajoli, A
700	1		_aJain, N
700	1		_aThompson, P A
700	1		_aJabbour, E
700	1		_aKanagal-Shamanna, R
700	1		_aPierce, S
700	1		_aAlousi, A
700	1		_aHosing, C
700	1		_aKhouri, I
700	1		_aEstrov, Z
700	1		_aCortes, J
700	1		_aKantarjian, H
700	1		_aRavandi, F
700	1		_aKadia, T M
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 7 _gp. 1554-1559
856	4	0	_uhttps://doi.org/10.1093/annonc/mdx163 _zAvailable from publisher's website
999			_c27051532 _d27051532